Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Ameratunga

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
The European Respiratory Journal|February 1, 1988
The alveolar carbon monoxide uptake fraction: a simple, alternative measure of carbon monoxide transferR Ameratunga, E A Harris
Clinical and Experimental Immunology|March 20, 2004
Increased risk of adverse events when changing intravenous immunoglobulin preparationsR Ameratunga, J Sinclair, J Kolbe
Postgraduate Medical Journal|February 10, 2009
Unstable angina following anaphylaxisR Ameratunga, M Webster, H Patel
Pathology|February 24, 2001
The simultaneous presentation of sarcoidosis and common variable immune deficiencyR Ameratunga, D M Becroft, W Hunter
The Journal of Rheumatology|March 1, 1989
Metastatic malignancy associated with reflex sympathetic dystrophyR Ameratunga, M Daly, D E Caughey
Clinical Transplantation|January 11, 2000
The kinetics of CD154 (CD40L) expression in peripheral blood mononuclear cells of healthy subjects in liver allograft recipients and X-linked hyper-IgM syndromeA Bartlett, J McCall, R Ameratunga, et al.
The New Zealand Medical Journal|February 9, 1994
A survey of wasp sting injuries in urban Auckland from December to April in 1991/2 and 1992/3J J Dymock, S A Forgie, R Ameratunga
Clinical and Experimental Immunology|July 2, 2019
Transient hypogammaglobulinaemia of infancy: many patients recover in adolescence and adulthoodR Ameratunga, Y Ahn, R Steele, et al.
The New Zealand Medical Journal|November 25, 1987
Reactive arthritis caused by Yersinia enterocoliticaR Ameratunga, T Lambert, D M Daly, et al.
Clinical and Experimental Immunology|July 18, 2013
New diagnostic criteria for common variable immune deficiency (CVID), which may assist with decisions to treat with intravenous or subcutaneous immunoglobulinR Ameratunga, S-T Woon, D Gillis, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
The European Respiratory Journal|February 1, 1988
The alveolar carbon monoxide uptake fraction: a simple, alternative measure of carbon monoxide transferR Ameratunga, E A Harris
Clinical and Experimental Immunology|March 20, 2004
Increased risk of adverse events when changing intravenous immunoglobulin preparationsR Ameratunga, J Sinclair, J Kolbe
Postgraduate Medical Journal|February 10, 2009
Unstable angina following anaphylaxisR Ameratunga, M Webster, H Patel
Pathology|February 24, 2001
The simultaneous presentation of sarcoidosis and common variable immune deficiencyR Ameratunga, D M Becroft, W Hunter
The Journal of Rheumatology|March 1, 1989
Metastatic malignancy associated with reflex sympathetic dystrophyR Ameratunga, M Daly, D E Caughey
Clinical Transplantation|January 11, 2000
The kinetics of CD154 (CD40L) expression in peripheral blood mononuclear cells of healthy subjects in liver allograft recipients and X-linked hyper-IgM syndromeA Bartlett, J McCall, R Ameratunga, et al.
The New Zealand Medical Journal|February 9, 1994
A survey of wasp sting injuries in urban Auckland from December to April in 1991/2 and 1992/3J J Dymock, S A Forgie, R Ameratunga
Clinical and Experimental Immunology|July 2, 2019
Transient hypogammaglobulinaemia of infancy: many patients recover in adolescence and adulthoodR Ameratunga, Y Ahn, R Steele, et al.
The New Zealand Medical Journal|November 25, 1987
Reactive arthritis caused by Yersinia enterocoliticaR Ameratunga, T Lambert, D M Daly, et al.
Clinical and Experimental Immunology|July 18, 2013
New diagnostic criteria for common variable immune deficiency (CVID), which may assist with decisions to treat with intravenous or subcutaneous immunoglobulinR Ameratunga, S-T Woon, D Gillis, et al.
Pageof 2